JANX
Janux Therapeutics Inc Earnings
$24.07
Earnings Summary
Revenue | $0Mn |
Net Profits | $-33.86Mn |
Net Profit Margins | -Inf% |
Janux Therapeutics Inc’s revenue fell -100% since last year same period to $0Mn in the Q2 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Janux Therapeutics Inc’s net profit fell -468.18% since last year same period to $-33.86Mn in the Q2 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated -44.03% fall in its net profits since last 3-months.
Janux Therapeutics Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q2 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.62 |
EPS Estimate Current Year | -0.62 |
Janux Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.62 - a -35.32% fall from last quarter’s estimates.
Janux Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.62.
Key Ratios
Earning Per Share (EPS) | 0 |
Janux Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Janux Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-11 | -0.62 | 0 | 100% |
2025-08-07 | -0.46 | -0.55 | -19.25% |
2025-05-08 | -0.39 | -0.38 | 2.99% |
